94 results
Page 3 of 5
8-K
EX-10.1
myvjxq
8 Jun 21
Departure of Directors or Certain Officers
2:43pm
8-K
EX-99.1
zgww 4bj0
13 May 21
UroGen Pharma Reports First Quarter 2021 Financial Results and Recent Corporate Developments
7:40am
DEFA14A
vmawxscpz
28 Apr 21
Additional proxy soliciting materials
4:04pm
8-K
EX-99.1
iffmd5i u5
18 Mar 21
UroGen Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Developments
8:13am
8-K
EX-99.1
7ta2owuj usjj
18 Mar 21
UroGen Pharma Announces $75 Million of Non-Dilutive Funding from RTW Investments
8:10am
8-K
EX-99.1
01lzin60
11 Jan 21
Regulation FD Disclosure
8:31am
8-K
EX-99.1
tmq2o8q9yb
9 Nov 20
UroGen Pharma Reports Third Quarter 2020 Financial Results and Recent Corporate Developments
8:13am
8-K
EX-10.2
0ognqmc87ob
9 Sep 20
Departure of Directors or Certain Officers
8:02am
8-K
EX-99.1
n1njlm yx5t1bjdwl
10 Aug 20
UroGen Pharma Reports Second Quarter 2020 Financial Results and Recent Corporate Developments
7:20am
8-K
EX-10.1
bhgromze50iq
10 Jun 20
Changes in Registrant's Certifying Accountant
4:16pm
DEFA14A
cmwlgwt7boouzfy
29 Apr 20
Additional proxy soliciting materials
6:53am